Previous 10 | Next 10 |
Accolade, Inc. (ACCD) Q2 2022 Earnings Conference Call October 7, 2021, 04:30 PM ET Company Participants Todd Friedman - SVP, IR Rajeev Singh - CEO Steve Barnes - CFO Shantanu Nundy - Chief Medical Officer Conference Call Participants Jailendra Singh - Credit Suisse Michael Cherny - Bank of A...
Fiscal second quarter 2022 revenue of $73.3 million, a 99% increase compared to fiscal second quarter 2021 revenue of $36.8 million Introduced Personalized Healthcare category, focused on human relationships and personalization using data to enable value-based care Launched Accola...
Insurtech Leader Announces New Employer-Paid Insurance Plan Featuring Virtual Primary Health Care, Dental Coverage and Investing Platform Connectivity for Hospitality Sector Employees PR Newswire DALLAS , Oct. 4, 2021 /PRNewswire/ -- Insurance Applications G...
Accolade introduces new healthcare category: Personalized Healthcare -Personalized Healthcare is focused on human relationships and personalization using data to enable value-based care. -Accolade also announces two new healthcare solutions -- Accolade One and Accolade Care ...
Accolade Invites Media, Investors and General Public to Opening of Evolve21 Accolade executives to make announcement during the opening keynotes at Evolve21, the company's annual customer event. PR Newswire SEATTLE , Sept. 20, 2021 /PRNewswire/ -- ...
SEATTLE, Sept. 16, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it will release fiscal second quarter 2022 financial results on Thursday, October 7, 2021, after the market closes. In conjunction, the company will host a conference call to review results at 4:3...
SEATTLE, Aug. 10, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), the company reinventing healthcare by helping people live their healthiest lives, will participate in the 41st Annual Canaccord Genuity Growth Conference, including a presentation on Thursday, August 12, 2021 at 11:00...
Last week was a terrible week for top growth stocks, as many of them with the highest expected sales growth were down big. Media fearmongering remains high with rising inflation, "pandemic-trade" unwind narratives and divergent investor goals diluting pundit viewpoints. We share d...
As earnings season kicks into gear and more economic data gets released this week, we could see some volatility in the markets. That's why investors should avoid stocks that have been recently downgraded to a Sell or Strong Sell by our POWR Ratings system. Accolade (ACCD), Borr Drilling (BORR...
Accolade, Inc. (ACCD) Q1 2022 Earnings Conference Call July 08, 2021, 04:30 PM ET Company Participants Todd Friedman - SVP, IR Rajeev Singh - CEO Steve Barnes - CFO Shantanu Nundy - Chief Medical Officer Conference Call Participants David Grossman - Stifel Michael Cherny - Bank of America Ric...
News, Short Squeeze, Breakout and More Instantly...
NEW YORK, NY / ACCESSWIRE / July 21, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Accolade, Inc. ("Accolade" or "the Company") (NASDAQ:ACCD). Investors who purchased Accolade securities are encouraged to obtain additional information ...
NEW YORK, NY / ACCESSWIRE / July 15, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Accolade, Inc. ("Accolade" or "the Company") (NASDAQ:ACCD). Investors who purchased Accolade securities are encouraged to obtain additional information ...
NEW YORK, NY / ACCESSWIRE / July 11, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Accolade, Inc. ("Accolade" or "the Company") (NASDAQ:ACCD). Investors who purchased Accolade securities are encouraged to obtain additional information ...